Industry News_News_Viva Biotech (Shanghai) Ltd.

Viva Biotech and Langhua Pharmaceutical Reached the Strategic Acquisition Agreement, Accelerating the Integration and Escalation of the Service Chain of Innovative Drug Industry

1 day ago

August 8th, 2020, Viva Biotech (Shanghai) Co., Ltd. entered into the Share Purchase Agreement pursuant and the Vendors agreed to collectively sell 80% of the equity interest in Zhejiang Langhua Pharmaceutical Co., Ltd.

View details

ABM Therapeutics has Completed A + Round Financing of 20 Million US Dollars

3 days ago

This round of financing will be used to accelerate the clinical research and development of ABM-1310 and several existing preclinical projects.

View details

Dr. David Xu, Chief Business Officer of Viva Biotech: Innovative drugs must effectively address unmet clinical needs

2020-08-05 10:34

“New breakthroughs in scientific research do not necessarily solve specific practical problems, but innovative drugs must effectively address clinical needs.”

View details

Viva Biotech Announces Strategic Partnership with Harbour BioMed to Collaborate on Incubating Innovative Biotech Start-ups

2020-07-31 07:42

Both parties will collate their respective expertise in drug discovery and development to promote the incubation of innovative biotech startups.

View details

Viva Biotech and Schrödinger Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets

2020-07-28 19:30

A strategic collaboration to expand the reach of structure-based drug discovery by generating de novo crystal structures of high-value targets.

View details

Page up

...

Page down